By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneGo today said that the National Cancer Institute has awarded the firm a Phase II Small Business Innovation Research grant to fund further development of an analytical platform for translational research and data analysis in oncology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.